Stephen Boulton

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutonomous vehicle systemsAgricultural molecular engineering of nucleic acids and proteinsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 22, 2026
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgery.

Stephen Boulton, Siddharth Singh, Bailey Organ

|Aug 23, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.

Zaid Taha, Mathieu Joseph François Crupi, Nouf Alluqmani

|May 26, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.

Taha Azad, Reza Rezaei, Ragunath Singaravelu

|Jan 21, 2023
Extracellular Vesicles and Viruses: Two Intertwined Entities.

Coline Moulin, Mathieu J F Crupi, Carolina S Ilkow

|Apr 17, 2020
Mechanism of Action of an EPAC1-Selective Competitive Partial Agonist.

Hongzhao Shao, Hebatallah Mohamed, Stephen Boulton

Pageof 1

Frequent Collaborators

3 joint publications

John Cameron Bell

2 joint publications

Mathieu Joseph François Crupi

1 joint publications

Jia Zhou

1 joint publications

Jakob Magolan